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5.1 INTRODUCTION 
 
 Dengue infections are due to several types of dengue 
viruses.  Initially, it was difficult to differentiate dengue fever 
since its characteristics is similar to some other diseases.  An early 
study reported that between the years 1780 to 1940, a unique 
characteristic associated with dengue-like illness was the relatively 
infrequent but often large epidemics [1].  New dengue virus strains 
and serotypes were identified (DEN-1 in 1977, a new strain of 
DEN-2 in 1981, DEN-4 in 1981, a new  
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strain of DEN-3 in 1994) [1].  They belong to the genus Flavivirus, 
family Flaviviridae, which contains approximately 70 viruses [1].  
All flaviviruses have common group epitopes on the envelope 
protein that result in extensive cross-reactions in serological test.  
These make unequivocal serological diagnosis of flaviviruses 
difficult.  Infection with one dengue serotype provides lifelong 
immunity to that virus, but there is no cross-protective immunity to 
other serotypes.  Thus, persons living in an area of endemic dengue 
can be infected with three, and probably four, dengue serotypes 
during their lifetime [1].   
 
 Typical case of DHF is characterized by acute fever 
associated with reflecting a mild degree of plasma leakage; when 
the plasma loss is critical, it develops shock, which can lead to 
mortality.  Several additional unique symptoms belong to DHF 
such as petechiae, ecchymoses, bleeding from the mucosa, 
injection sites and haematemesis can only be discriminated by 
medical experts.  The cases of DHF have been graded, according 
to the WHO specification, into four grades[2].  Grade I is defined 
as having a fever accompanied by non-specific constitutional 
symptoms, the only haemorrhagic manifestation is a positive 
touniquet test that results in petechial rash.  Grade II is defined as 
patients having a spontaneous bleeding from any site of their body, 
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i.e. skin.  Grade III is patients with circulatory failure manifested 
by rapid and weak pulse, narrowing of pulse pressure (20mmHg or 
less) or hypotension, with the presence of cold clammy skin and 
restlessness.  Grade IV is defined as patients having profound 
shock with undetectable blood and pulse.   
 
 DHF with plasma leakage may lead to dengue shock 
syndrome (DSS).  The condition of patients who progress to shock 
suddenly deteriorates after a fever of 2-7 days duration.  This 
deterioration occurs at the time of, or shortly after, the fall in 
temperature-between the third and the seventh day of the disease.  
There are the typical signs of circulatory failure: the skin becomes 
cool, blotchy and congested; circumoral cyanosis is frequently 
observed; the pulse becomes rapid.  Patients may initially be 
lethargic, then become restless and rapidly enter a critical stage of 
shock.  Acute abdominal pain is a frequent complaint shortly 
before the onset of shock. 
 
 
 
 
5.2 EPIDEMIOLOGY 
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 The first major outbreak of DHF in Malaysia occurred in 
1973.  DEN-3 was considered to be the main causal type [3].  In 
1998, the country experienced a large epidemic with 15493 
notified cases, where 799 were cases of DHF with 99 deaths [4].  It 
was thought that the El Nino weather phenomenon may have 
influenced the dengue infection [5].  It was warned that global 
warming has affected the pattern of dengue fever in several ways.  
Figure 5.1  shows the trend of dengue situation in Malaysia from 
the year 1988 to 2001 [4] [6].  The incidence rate of clinically 
diagnosed DF and DHF reported shows an upward trend from 8.5 
cases/100,000 populations in 1988 to 123.4 cases/100,000 
population in 1998.  Out of the 16,368 cases reported in the year 
2001, 22% were among children 14 years and below.  Similarly the 
case fatality rate (CFR) for DF is high, ranging from 5% to 6% per 
annum for both children and adults.  As expected, there have been 
more cases of DF than DHF, with a ratio of 16 – 25:1 over the last 
5 years.  In the year 2001, the DF:DHF ratio in children was 6.7:1 
as compared to 27.3:1 in adults. 
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Figure 5.1  Number of cases, deaths and incidence rates (per 
100,000) in Malaysia, 1988-2003[6].  
 
 
 
5.3 BIOELECTRICAL IMPEDANCE ANALYSIS 
 
 The BIA measurements were conducted by way of a 
tetrapolar configuration [7] using the BIA 450 analyzer (Figure 
5.2). The four electrode technique used by this system largely 
avoided the aforementioned difficulties faced when using the two 
electrode technique. Four surface electrodes were used: two 
electrodes were placed on the subject’s right hand, one at the base 
of knuckles and another slightly above the wrist joint. Another two 
electrodes were placed on the right foot, one near the base of the 
toes and the other slightly above the ankle joint.  
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Figure 5.2 Principle of bioelectrical impedance measurement 
using the four electrode technique. A and B are the current source 
electrodes (less than 1mA) while C and D are detecting electrodes. 
 
 
 The BIA 450 analyzer delivered constant current less than 
1mA at 50 kHz into the tissue via the electrodes attached at base of 
the knuckles and base of the toes (current electrodes between 
points A and B) and the signal was picked up by the other two 
sensor electrodes (voltage electrodes between points C and D) 
slightly above the ankle and wrist joints as shown in Figure 5.3. 
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Figure 5.3 Electrodes placement on the right side of the wrist and 
ankle. Electrodes A and B are current sources while electrodes C 
and D are voltage pick-up [8]. 
 
 
 
5.4 PATIENTS AND METHODS 
 
 Two hundred ten adult patients aged 12 years old and 
above, suspected of DF and DHF admitted to the Universiti 
Kebangsaan Malaysia Hospital (HUKM), were monitored.  For the 
first group, the severity of the DHF is classified into grade I to IV, 
according to WHO recommendation [2].  Acute dengue infection 
was confirmed subsequently by the use of ELISA to detect 
Electrode C 
Electrode A 
Electrode D 
Electrode B 
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elevated dengue specific IgM (primary infection) and IgG 
(secondary infection) [9].  Patient serum samples were tested for 
hemoglobin determination using an automated counter (Coulter 
STKS machine).  The second group is the control group for 
healthy female and male subjects. 
 
 All patients were required to follow the following 
guidelines to ensure accurate body composition results, no 
drinking and eating intake for 4 hours prior to the test, no alcohol 
consumption for 24 hours prior to the test, no physical exercise for 
12 hours prior to the test.  The subjects were required to expose 
their right ankle and wrist during the BIA measurement.  Two 
electrodes were placed on the patient’s right hand, one the base of 
the knuckles and another slightly above the wrist joint.  Another 
two electrodes were placed on the right foot, one near the toes and 
the other slightly above the ankle joint. A constant current less 
than 1 mA and single frequency of 50 kHz was produced by a 
biodynamic Model 450 bioimpedance analyzer and injected to the 
base of the knuckles and base of the toes and the signal was picked 
up by the other two sensor electrodes.  Resistance, reactance, body 
capacitance and phase angle were measured by the BIA analyzer.  
The clinical data were recorded using the standardized 
questionnaire data collection. 
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 The second groups of patients (control subjects) who do not 
have past medical history of dengue were recruited and studied 
using the same guidelines as in the BIA subject preparation used 
for the first group. The BIA safety measurements procedure and 
other safety precautions were made known to the subjects and their 
informed consent was obtained from each subject prior to the BIA 
measurement. 
 
  For the control subject, the weight was taken once.  
However for subjects with dengue infection, the weight was 
measured daily until upon discharged.  
 
 
 
5.5 STATISTICAL ANALYSIS 
 
Statistics were calculated with SPSS version 11.5, using non-
parametric test because variables were not always normally 
distributed.  Correlations between variables were analyzed using 
Spearman’s rank correlation coefficient (ρ) and multiple linear 
regression analysis was used to determine the independent effect of 
parameters related with hemoglobin.  Statistical significance was 
defined as P < 0.05 for all tests. 
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5.6 RESULTS  
 
 Subjects were 210 patients, 119 males and 91 females with 
mean age of 30.65 years.  Correlations between variables were 
analyzed using Spearman’s correlation coefficient.  It is a 
standardized measure of the strength of the relationship between 
two variables that does not rely on the assumptions of a parametric 
test.   
 
 Linear regression was used to identify the most significant 
variable among the bioelectrical impedance analysis parameters.  
A significant variable were reactance, race, complication, 
headache and the day of fever (p<0.05). 
 
 Table 5.1 shows the model parameters.  This model 
includes 19 variables predicting the risk, but only five variables are 
highly significant. 
 
  
 
 
 
 
Recent Development in Instrumentation System 75 
 
 
 
Table 5.1 Significant parameters for 210 patients on day-of-
admissions. 
Unstandardized CoefficientsStandardized Coefficients 
B
(Constant) 0.928 3.855 0.000
RACE 0.099 2.777 0.006
COMPLICATION ‐0.037 ‐2.268 0.025
NO OF DAY 0.045 2.634 0.009
REACTANCE ‐0.013 ‐3.954 0.000
HEADACHE 0.200 2.219 0.028
DIZZFAIN ‐0.182 ‐1.740 0.084
WLIMB 0.124 1.195 0.234
ARTHALGIA 0.074 0.617 0.538
MYALGIA 0.002 0.014 0.989
BACKACHE 0.045 0.452 0.652
NAUSEA ‐0.077 ‐0.775 0.439
VOMITT ‐0.002 ‐0.020 0.984
ANOREXIA ‐0.003 ‐0.047 0.962
GASTRIC 0.051 0.663 0.508
P.RASH ‐0.022 ‐0.308 0.758
FLUSHF ‐0.036 ‐0.444 0.658
CHILLNR ‐0.043 ‐0.184 0.854
HEPA 0.070 0.723 0.470
BT 0.155 1.969 0.051
a. Dependent Variable:RISK
0.051
0.142
Model
‐0.143
0.089
0.051
0.001
0.037
‐0.065
0.082
0.233
0.097
0.079
0.193
‐0.153
0.179
‐0.276
0.163
0.099
0.099
0.177
0.072
0.077
0.072
0.003
0.090
0.105
0.103
0.120
0.120
Coefficients a
Std. Error Beta t Sig.
0.240
0.036
0.016
0.017
0.050
‐0.021
‐0.030
‐0.012
‐0.002
‐0.003
 
 
 
  Table 5. 2 System efficiency 
Model R R Square Adjusted  Std. Error 
R Square of the Estimate
1 0.539 0.291 0.212 0.441  
 
Finally linear regression was used to identify all significant 
variables and adjusted R2 to 29% (Table 5. 2).  Hence the final 
model can be written as follows: 
 
Risk = 0.926 + 0.099 (race) - 0.037 (complication) + 0.045 (the 
day of fever) – 0.013 (reactance) + 0.20 (headache). 
 
5.6 CONCLUSION 
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In this developed model, five predictors such as race, reactance, 
complication, headache and the day of fever were the best 
predictive factors for modeling the risk in dengue patients.  New 
non-invasive system to predicting the risk in DF and DHF was 
developed. 
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